Molecular cloning and expression of novel alternatively spliced cytochrome P450 2E1 mRNAs in humans
Related Experiment Video
Updated: Aug 14, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Mario Bauer1, Olf Herbarth, Gabi Aust
1Department of Human Exposure Research and Epidemiology, UFZ - Centre for Environmental Research Leipzig-Halle, Permoser street 15, 04318, Leipzig, Germany. mario.bauer@ufz.de
Abstract:
Human cytochrome P450 2E1 (CYP2E1) is a phase I metabolizing enzyme. It is involved in the biotransformation of xenobiotics and endogenous substrates. Inter-individual genetic polymorphisms of the CYP2E1 gene are associated with different cancer diseases as well as alcohol and nicotine dependence. We report here for the first time three novel alternative spliced mRNA transcripts which are more frequently present in lung carcinoma cell lines as in hepatocyte cell lines. They are unexpected detectable in blood leukocytes from healthy volunteers but not in normal and cancerous lung tissue. The full-length wildtype transcript of CYP2E1 is described to be concomitant to an alternatively spliced mRNA transcript. Stimulation with CYP2E1-inducing agents did not change the splicing transcript pattern. The three splicing variants should lead to truncated non-functional proteins. Thus the genetic diversity of CYP2E1 is additionally extended at the transcriptional level of gene expression. The physiological role of the splicing variants is not known, yet, but they seem to be related to the carcinogenic property of the cell lines.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
RACE - Rapid Amplification of cDNA Ends
Since the...

